Host: Rabbit
Target Protein: PP2A alpha / beta
Immunogen Range: 205-309/309
Clonality: Polyclonal
Isotype: IgG
Entrez Gene: 5515
Swiss Prot: P67775
Source: KLH conjugated synthetic peptide derived from human PP-2A
Purification: Purified by Protein A.
Storage Buffer: 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
Background:
Size: 100ul
Concentration: 1ug/ul
Applications:
WB(1:300-5000)
ELISA(1:500-1000)
FCM(1:20-100)
IHC-P(1:200-400)
IHC-F(1:100-500)
IF(IHC-P)(1:50-200)
IF(IHC-F)(1:50-200)
IF(ICC)(1:50-200)
Predicted Molecular Weight: 34
Cross Reactive Species:
Human
Mouse
Predicted Cross Reactive Species:
Rat
Dog
Cow
Pig
Chicken
Rabbit
For research use only. Not intended for diagnostic or therapeutic use.
- Zhao, Hai-hua, et al. "Involvement of GSK3 and PP2A in ginsenoside Rb1's attenuation of aluminum-induced tau hyperphosphorylation." Behavioural Brain Research (2012).Read more>>
- Lin, Lai-xiang, et al. "Feasibility of β-Sheet Breaker Peptide-H102 Treatment for Alzheimers Disease Based on β-Amyloid Hypothesis." PLoS one 9.11 (2014): e112052.Read more>>
Formalin-fixed and paraffin embedded human lung carcinoma labeled with Anti-PP2A alpha + beta Polyclonal Antibody, Unconjugated (bs-0029R) at 1:200 followed by conjugation to the secondary antibody and DAB staining
Paraformaldehyde-fixed, paraffin embedded mouse brain; Antigen retrieval by boiling in sodium citrate buffer (pH6) for 15min; Block endogenous peroxidase by 3% hydrogen peroxide for 30 minutes; Blocking buffer (normal goat serum) at 37°C for 20min; Antibody incubation with PP2A alpha + beta Polyclonal Antibody, Unconjugated (bs-0029R)at 1:400 overnight at 4°C, followed by a conjugated secondary and DAB staining.
Lane 1: Liver lysates; Lane 2: Kidney lysates; Lane 3: Muscle lysates probed with PP2A alpha + beta Polyclonal Antibody, Unconjugated (bs-0029R) at 1:300 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:10000 for 60 min at 37˚C.
Lane 1: Muscle lysates; Lane 2: Heart lysates probed with PP2A alpha + beta Polyclonal Antibody, Unconjugated (bs-0029R) at 1:300 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:10000 for 60 min at 37˚C.
Lane 1: U937 lysates; Lane 2: HL-60 lysates probed with PP2A alpha + beta Polyclonal Antibody, Unconjugated (bs-0029R) at 1:300 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:10000 for 60 min at 37˚C.
Hela cells were fixed with 4% PFA for 10min at room temperature,permeabilized with 90% ice-cold methanol for 20 min at -20℃, and incubated in 5% BSA blocking buffer for 30 min at room temperature. Cells were then stained with PP2A alpha / beta Polyclonal Antibody(bs-0029R)at 1:50 dilution in blocking buffer and incubated for 30 min at room temperature, washed twice with 2%BSA in PBS, followed by secondary antibody incubation for 40 min at room temperature. Acquisitions of 20,000 events were performed. Cells stained with primary antibody (green), and isotype control (orange).
Paraformaldehyde-fixed, paraffin embedded (mouse brain); Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15min; Block endogenous peroxidase by 3% hydrogen peroxide for 20 minutes; Blocking buffer (normal goat serum) at 37°C for 30min; Antibody incubation with (PP2A alpha + beta) Polyclonal Antibody, Unconjugated (bs-0029R) at 1:200 overnight at 4°C, followed by operating according to SP Kit(Rabbit) (sp-0023) instructionsand DAB staining.
Lane 1: Mouse Kidney tissue lysates; Lane 2: Mouse NIH/3T3 cell lysates; Lane 3: Rat Kidney tissue lysates; Lane 4: Human Hela cell lysates; Lane 5: Human A431 cell lysates; Lane 6: Human HepG2 cell lysates; Lane 7: Human MOLT4 cell lysates probed with PP2A alpha + beta Polyclonal Antibody, Unconjugated (bs-0029R) at 1:1000 dilution and 4°C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.